| Product Code: ETC7923493 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Latvia`s import market for transdermal scopolamine patches continued to show steady growth in 2024, with top exporting countries being Lithuania, Netherlands, Switzerland, Poland, and Germany. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained at a low level, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was a strong 8.6%, with a notable growth rate of 7.03% from 2023 to 2024. These trends suggest a positive outlook for the transdermal scopolamine patch market in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Transdermal Scopolamine Patch Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Transdermal Scopolamine Patch Market - Industry Life Cycle |
3.4 Latvia Transdermal Scopolamine Patch Market - Porter's Five Forces |
3.5 Latvia Transdermal Scopolamine Patch Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Transdermal Scopolamine Patch Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Transdermal Scopolamine Patch Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia Transdermal Scopolamine Patch Market Trends |
6 Latvia Transdermal Scopolamine Patch Market, By Types |
6.1 Latvia Transdermal Scopolamine Patch Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, By 1mg, 2021- 2031F |
6.1.4 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, By 1.5mg, 2021- 2031F |
6.2 Latvia Transdermal Scopolamine Patch Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, By Motion Sickness, 2021- 2031F |
6.2.3 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, By Nausea/Vomiting, 2021- 2031F |
6.2.4 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, By Parkinsonian Tremor, 2021- 2031F |
6.2.5 Latvia Transdermal Scopolamine Patch Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Transdermal Scopolamine Patch Market Import-Export Trade Statistics |
7.1 Latvia Transdermal Scopolamine Patch Market Export to Major Countries |
7.2 Latvia Transdermal Scopolamine Patch Market Imports from Major Countries |
8 Latvia Transdermal Scopolamine Patch Market Key Performance Indicators |
9 Latvia Transdermal Scopolamine Patch Market - Opportunity Assessment |
9.1 Latvia Transdermal Scopolamine Patch Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Transdermal Scopolamine Patch Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Transdermal Scopolamine Patch Market - Competitive Landscape |
10.1 Latvia Transdermal Scopolamine Patch Market Revenue Share, By Companies, 2024 |
10.2 Latvia Transdermal Scopolamine Patch Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |